Holen Sie sich die Stockscreener-App
9.33
1.86%
0.17
Handel nachbörslich:
9.33
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Dana Carrera, Tasso Partners disclose 15.3% stake in PAVmed (NASDAQ: PAVM) - Stock Titan
70,000-share PAVmed (PAVM) restricted stock grant to CMO - Stock Titan
[Form 3] PAVmed Inc. Initial Statement of Beneficial Ownership - Stock Titan
Scopia Holdings/Member Matthew Sirovich reports 9.99% in PAVmed (PAVM) - Stock Titan
Risk Report: Is PAVmed Inc forming higher highs and higher lows2026 Technicals & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow
PAVmed (PAVM) price target decreased by 16.51% to 268.26 - MSN
Treasury Yields: Is PAVmed Inc a potential multi bagger2026 Summary & High Return Trade Guides - baoquankhu1.vn
Aug Reactions: Can PAVmed Inc expand into new markets2026 Snapshot & Weekly Stock Performance Updates - baoquankhu1.vn
Lishan Aklog Discloses Investment at PAVmed Inc. with 5.1% Stake - TradingView — Track All Markets
PAVmed (PAVM) CEO Aklog reports 5.1% stake and 350,000 restricted shares - Stock Titan
Lucid Diagnostics CEO to Participate in Healthcare Conference - Intellectia AI
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Barchart
Entry Recap: Can PAVmed Inc be recession proofQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
How The PAVmed (PAVM) Narrative Is Shifting After The Latest Analyst Reassessment - Yahoo Finance
Nagelberg disclosures show 8.6% ownership in PAVmed (NASDAQ: PAVM) - Stock Titan
Aug PostEarnings: Can PAVmed Inc sustain its profitability2026 Growth vs Value & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
PAVmed (NASDAQ: PAVM) Scott Dols reports 5.4% stake, 346,155 shares - Stock Titan
PAVM Appoints Joseph Virgilio to Oversee Revamp of Medical Device Portfolio - Bitget
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch - Yahoo Finance
Tasso Partners, LLC (PAVM) reports large PAVmed stake and warrant position - Stock Titan
EV Market: Will PAVmed Inc benefit from rate cuts2026 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Big Money Moves: Whats next for PAVmed Inc stockBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PAVmed (PAVM) CEO Lishan Aklog awarded 350,000 restricted shares vesting 2029 - Stock Titan
Craig Kallman (PAVM) holds 384,616 shares, a 6.0% stake in PAVmed - Stock Titan
PAVmed (PAVM) CFO awarded 180,000 restricted shares vesting 2029 - Stock Titan
Director at PAVmed (PAVM) receives 13,930 restricted stock shares - Stock Titan
PAVmed (PAVM) director Timothy Baxter receives 13,930 restricted shares vesting in 2029 - Stock Titan
Restricted stock grant boosts PAVmed (PAVM) director’s holdings - Stock Titan
PAVmed (PAVM) director gets 13,930-share restricted stock grant - Stock Titan
Restricted stock award boosts PAVmed (NASDAQ: PAVM) director stake - Stock Titan
Tasso Partners and Dana Carrera disclose 14.3% stake in PAVmed (PAVM) - Stock Titan
PAVmed (PAVM) general counsel receives 110,000-share restricted award - Stock Titan
PAVmed (PAVM) COO receives 110,000-share restricted stock grant vesting 2029 - Stock Titan
Lucid Diagnostics Inc. (LUCD) stock price, news, quote and history - Yahoo Finance UK
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - Bitget
PAVmed appoints Joseph Virgilio as medical device chief By Investing.com - Investing.com Australia
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed Appoints New Executive to Drive Medical Device Development - Intellectia AI
PAVmed: Octeris, Inc. Subsidiary Formed to Advance Endoscopic Esophageal Imaging Tech Recently Licensed From Duke University >PAVM - Moomoo
PAVmed appoints Joseph Virgilio as medical device chief - Investing.com
PAVmed Inc. (NASDAQ:PAVM) Q4 2025 Earnings Call Transcript - Insider Monkey
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Cuts Target Price to $16 - Moomoo
PAVmed Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Fundamentals Check: Is PAVmed Inc a potential multi baggerWeekly Profit Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
PAVmed completes $45M financing, eliminates convertible debt By Investing.com - Investing.com Australia
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Re - GuruFocus
PAVmed Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-03-30 - Seeking Alpha
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
PAVM: Q4 2025 featured diagnostic revenue growth, a VA contract, and improved non-GAAP loss per share - TradingView
PAVmed Reports 2025 Financial Results, Strengthens Capital Structure, and Expands Medical Device Portfolio Under New Leadership - Minichart
Earnings call transcript: PAVmed Q4 2025 shows restructuring gains By Investing.com - Investing.com India
2.40%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):